NCT00631592View on ClinicalTrials.gov

GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study

PHASE1CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions

Healthy Subjects

Interventions

DRUG

GSK1349572

Trial Locations (1)

53704

GSK Investigational Site, Madison

Sponsors

Lead Sponsor

ViiV Healthcare

All Listed Sponsors

lead

ViiV Healthcare

INDUSTRY

NCT00631592 - GSK1349572 Repeat Dose Escalation and Relative Bioavailability Study | Biotech Hunter | Biotech Hunter